UK experimental use exemptions: part 1—the original
In the first of a four-part series, Sophie Topham of Marks & Clerk explores how experimental use provides life sciences products with essential relief from patent infringement
Latest news
Shionogi and Duchesnay add new patents to Osphena dispute
05-08-2021
Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena—a treatment for vaginal pain during sex.
Regions
Sectors
- UK experimental use exemptions: Part 3—the expanded exemption 05-08-2021
- Growing pains 03-08-2021
